[HTML][HTML] Stem cell-based therapy for human diseases

DM Hoang, PT Pham, TQ Bach, ATL Ngo… - Signal transduction and …, 2022 - nature.com
Recent advancements in stem cell technology open a new door for patients suffering from
diseases and disorders that have yet to be treated. Stem cell-based therapy, including …

[HTML][HTML] Neutrophil elastase and chronic lung disease

JA Voynow, M Shinbashi - Biomolecules, 2021 - mdpi.com
Neutrophil elastase (NE) is a major inflammatory protease released by neutrophils and is
present in the airways of patients with cystic fibrosis (CF), chronic obstructive pulmonary …

Effect of minimally invasive surfactant therapy vs sham treatment on death or bronchopulmonary dysplasia in preterm infants with respiratory distress syndrome: the …

PA Dargaville, COF Kamlin, F Orsini, X Wang… - Jama, 2021 - jamanetwork.com
Importance The benefits of surfactant administration via a thin catheter (minimally invasive
surfactant therapy [MIST]) in preterm infants with respiratory distress syndrome are …

[HTML][HTML] Single cell transcriptomic analysis of murine lung development on hyperoxia-induced damage

M Hurskainen, I Mižíková, DP Cook… - Nature …, 2021 - nature.com
During late lung development, alveolar and microvascular development is finalized to
enable sufficient gas exchange. Impaired late lung development manifests as …

Pulmonary surfactant: a mighty thin film

F Possmayer, YY Zuo, RAW Veldhuizen… - Chemical …, 2023 - ACS Publications
Pulmonary surfactant is a critical component of lung function in healthy individuals. It
functions in part by lowering surface tension in the alveoli, thereby allowing for breathing …

[HTML][HTML] Neutrophil elastase: From mechanisms to therapeutic potential

W Zeng, Y Song, R Wang, R He, T Wang - Journal of Pharmaceutical …, 2023 - Elsevier
Neutrophil elastase (NE), a major protease in the primary granules of neutrophils, is
involved in microbicidal activity. NE is an important factor promoting inflammation, has …

[HTML][HTML] Pulmonary hypertension in bronchopulmonary dysplasia

G Hansmann, H Sallmon, CC Roehr… - Pediatric …, 2021 - nature.com
Bronchopulmonary dysplasia (BPD) is a major complication in prematurely born infants.
Pulmonary hypertension (PH) associated with BPD (BPD-PH) is characterized by alveolar …

Diagnosis and management of bronchopulmonary dysplasia

M Gilfillan, A Bhandari, V Bhandari - Bmj, 2021 - bmj.com
Bronchopulmonary dysplasia (BPD) is the most common chronic lung disease in infants and
is associated with increased mortality, respiratory morbidity, neurodevelopmental …

Patent ductus arteriosus and bronchopulmonary dysplasia–associated pulmonary hypertension: a bayesian meta-analysis

E Villamor, E van Westering-Kroon… - JAMA Network …, 2023 - jamanetwork.com
Importance Bronchopulmonary dysplasia (BPD) is often associated with pulmonary vascular
disease and secondary pulmonary hypertension (PH). The pathogenesis of BPD-associated …

[HTML][HTML] Present and future of bronchopulmonary dysplasia

L Bonadies, P Zaramella, A Porzionato… - Journal of clinical …, 2020 - mdpi.com
Bronchopulmonary dysplasia (BPD) is the most common respiratory disorder among infants
born extremely preterm. The pathogenesis of BPD involves multiple prenatal and postnatal …